当前位置: 首页 > 详情页

ERK pathway activation is required for amyloid-beta(1-40)-induced neurotoxicity of THP-1 human monocytes towards SK-N-SH neuroblastoma

文献详情

资源类型:
WOS体系:

收录情况: ◇ SCIE

机构: [a]Department of Pharmacology, Xuan-wu Hospital of Capital Medical University, Education Ministry Key Laboratory for Neurodegenerative Disease, 45 Chang-chun Street, Beijing, 100053, PR China [b]Department of Neurology, Henan Provincial People's Hospital, 7 Wei-wu Road, Zhengzhou, Henan Province, 450003, PR China
出处:
ISSN:

关键词: Amyloid-beta(1-40) Inflammation THP-1 monocyte SK-N-SH neuroblastoma cell PTK/MEK/ERK pathway

摘要:
Alzheimer's disease (AD) is characterized by amyloid-beta peptide deposition, increased activated microglia, and progressive loss of neurons in the brain. Although A beta(1-40) can elicit inflammation in microglia, the intracellular signaling events mediating these effects are poorly defined. Here we show that cell-free supernatant from A beta(1-40)-treated THP-1 monocytes induced cytotoxicity towards neuroblastoma SK-N-SH cells. Exposure of THP-1 monocytes to A beta(1-40) leads to increased tyrosine phosphorylation and extracellular signaling-regulated kinase (ERK) and increased levels of inflammatory cytokines (IL-1 beta, IL-8, and TNF-alpha) in the supernatant of THP-1 monocytes. Pretreatment of THP-1 monocytes with either a protein tyrosine kinase (PTK) inhibitor or an ERK inhibitor protects SK-N-SH cells from the cytotoxic effect of conditional supernatant from A beta(1-40)-treated THP-1 monocytes. A beta(1-40)-treated THP-1 monocytes also lead to upregulation of cyclooxygenase-2 and iNOS expression and increased of nitric oxide production. These results suggest that A beta(1-40)-induced activation of PTK/MEK/ERK pathway in THP-1 monocytes leads to the release of inflammatory factors that are toxic to SK-N-SH cells and might contribute to the onset of AD. Crown Copyright (C) 2011 Published by Elsevier B.V. All rights reserved.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2010]版:
大类 | 3 区 医学
小类 | 4 区 神经科学
最新[2023]版:
大类 | 4 区 医学
小类 | 4 区 神经科学
JCR分区:
出版当年[2009]版:
Q3 NEUROSCIENCES
最新[2023]版:
Q3 NEUROSCIENCES

影响因子: 最新[2023版] 最新五年平均 出版当年[2009版] 出版当年五年平均 出版前一年[2008版] 出版后一年[2010版]

第一作者:
第一作者机构: [a]Department of Pharmacology, Xuan-wu Hospital of Capital Medical University, Education Ministry Key Laboratory for Neurodegenerative Disease, 45 Chang-chun Street, Beijing, 100053, PR China
共同第一作者:
通讯作者:
通讯机构: [a]Department of Pharmacology, Xuan-wu Hospital of Capital Medical University, Education Ministry Key Laboratory for Neurodegenerative Disease, 45 Chang-chun Street, Beijing, 100053, PR China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:16461 今日访问量:0 总访问量:871 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持:重庆聚合科技有限公司 地址:北京市西城区长椿街45号宣武医院